Countries which Primarily Use Antimalarial Drugs As COVID-19 Treatment See Slower Dynamic of Daily Deaths

Izoulet M., SSRN, doi:10.2139/ssrn.3575899

Apr 2020

Source PDF All Studies Meta AnalysisMeta

Compares the dynamics of daily deaths in the 10 days following the 3rd death in countries using and not using [H]CQ, showing dramatically lower death in [H]CQ countries. This paper does not attempt to account for population age and other differences between the countries and recommends further study. This study is excluded in the after exclusion results of meta analysis: excessive unadjusted differences between groups.

Important missing comments or errors? Let us know.

risk of death, 85.0% lower, RR 0.15, p < 0.001.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Izoulet et al., 21 Apr 2020, retrospective, multiple countries, preprint, 1 author, dosage not specified.

All Studies Meta Analysis Submit Updates or Corrections

This Paper HCQ All

Abstract: d Countries which Primarily use Antimalarial Drugs as 5 ev iew e COVID-19 Treatment See Slower Dynamic of daily Deaths Maxime Izoulet, CEMI-EHESS, Paris.

Late treatment
is less effective

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

@CovidAnalysis

FAQ

Public domain CC0 1.0